APICES Acknowledged for its Role in GEOCP-SEOR Study 

by Bilyana Petrova | Dec 2, 2025 | News

APICES CRO is pleased to announce its contribution to the GEOCP-SEOR study. This is a RWE Study in Non Small Cell Lung Cancer (NSCLC), recently featured in the Cancers Journal.  The study evaluates and provide real-world...

How Artificial Intelligence Is Transforming Drug Development in Europe 

by Bilyana Petrova | Nov 10, 2025 | News

Insights from Óscar Salamanca, CEO of APICES, President of the Spanish Association of Clinical Research Companies (AECIC)  Artificial intelligence (AI) is transforming the landscape of clinical research and drug development. From predictive analytics and trial...

Key takeaways from ESMO Congress 2025 in Berlin

by Bilyana Petrova | Oct 29, 2025 | News

The 2025 edition of the European Society for Medical Oncology (ESMO) Congress, held in Berlin from October 17-21, offered a wealth of data and signals for the evolving landscape of oncology clinical research. For executives in Pharma and Biotech focused on...

APICES Acknowledged for its Role in CANTABRICO Clinical Trial 

by Bilyana Petrova | Oct 22, 2025 | News

APICES CRO is pleased to announce its contribution to the CANTABRICO study. This is a Phase IIIb clinical trial in Small Cell Lung Cancer (SCLC), recently featured in the Elsevier Lung Cancer Journal.  The study evaluates first-line treatment in...

7 Questions Every Biotech CEO Should Ask Before Outsourcing an Oncology Trial in Europe 

by Bilyana Petrova | Oct 1, 2025 | News

Outsourcing an Oncology Trial in Europe: 7 Questions for Biotech CEOs If you’re a biotech CEO weighing where and with whom to run oncology clinical trials in Europe, the margin for error is thin. Even though the EU’s Clinical Trials Regulation (CTR 536/2014) has...

APICES acknowledged for its role in PALBOBIN clinical trial 

by Bilyana Petrova | Sep 24, 2025 | News

We are proud to announce that APICES has been acknowledged for its ongoing collaboration in PALBOBIN Trial, a Phase IB clinical trial in Breast Cancer (TNBC). This acknowledgement was highlighted in the Journal of Cancer Research Communications. ...